Suppr超能文献

新型氘代吡唑并喹啉酮配体(DK-I-56-1)的冻干纳米晶分散体:通过稳定性研究确定工艺参数和冻干保护剂的选择

Freeze-dried nanocrystal dispersion of novel deuterated pyrazoloquinolinone ligand (DK-I-56-1): Process parameters and lyoprotectant selection through the stability study.

作者信息

Mitrović Jelena R, Bjelošević Žiberna Maja, Vukadinović Aleksandar, Knutson Daniel E, Sharmin Dishary, Kremenović Aleksandar, Ahlin Grabnar Pegi, Planinšek Odon, Lunter Dominique, Cook James M, Savić Miroslav M, Savić Snežana D

机构信息

Department of Pharmaceutical Technology and Cosmetology, University of Belgrade-Faculty of Pharmacy, Vojvode Stepe 450, Belgrade 11221, Serbia.

Department of Pharmaceutical Technology, University of Ljubljana, Faculty of Pharmacy, Aškerčeva 7, 1000, Ljubljana, Slovenia.

出版信息

Eur J Pharm Sci. 2023 Oct 1;189:106557. doi: 10.1016/j.ejps.2023.106557. Epub 2023 Aug 6.

Abstract

Recently, nanocrystal dispersions have been considered as a promising formulation strategy to improve the bioavailability of the deuterated pyrazoloquinolinone ligand DK-I-56-1 (7‑methoxy-2-(4‑methoxy-d3-phenyl)-2,5-dihydro-3H-pyrazolo[4,3-c]quinolin-3-one). In the current study, the freeze-drying process (formulation and process parameters) was investigated to improve the storage stability of the previously developed formulation. Different combinations of lyoprotectant (sucrose or trehalose) and bulking agent (mannitol) were varied while formulations were freeze-dried under two conditions (primary drying at -10 or -45 °C). The obtained lyophilizates were characterized in terms of particle size, solid state properties and morphology, while the interactions within the samples were analyzed by Fourier transform infrared spectroscopy. In the preliminary study, three formulations were selected based on the high redispersibility index values (around 95%). The temperature of primary drying had no significant effect on particle size, but stability during storage was impaired for samples dried at -10 °C. Samples dried at lower temperature were more homogeneous and remained stable for three months. It was found that the optimal ratio of sucrose or trehalose to mannitol was 3:2 at a total concentration of 10% to achieve the best stability (particle size < 1.0 μm, polydispersity index < 0.250). The amorphous state of lyoprotectants probably provided a high degree of interaction with nanocrystals, while the crystalline mannitol provided an elegant cake structure. Sucrose was superior to trehalose in maintaining particle size during freeze-drying, while trehalose was more effective in keeping particle size within limits during storage. In conclusion, results demonstrated that the appropriate combination of sucrose/trehalose and mannitol together with the appropriate selection of lyophilization process parameters could yield nanocrystals with satisfactory stability.

摘要

最近,纳米晶体分散体被认为是一种很有前景的制剂策略,可提高氘代吡唑并喹啉酮配体DK-I-56-1(7-甲氧基-2-(4-甲氧基-d3-苯基)-2,5-二氢-3H-吡唑并[4,3-c]喹啉-3-酮)的生物利用度。在当前研究中,对冷冻干燥过程(制剂和工艺参数)进行了研究,以提高先前开发制剂的储存稳定性。在两种条件下(-10或-45°C进行一次干燥)对制剂进行冷冻干燥时,改变了冻干保护剂(蔗糖或海藻糖)和填充剂(甘露醇)的不同组合。对获得的冻干产品进行粒度、固态性质和形态表征,同时通过傅里叶变换红外光谱分析样品内部的相互作用。在初步研究中,根据高再分散指数值(约95%)选择了三种制剂。一次干燥温度对粒度没有显著影响,但在-10°C干燥的样品在储存期间的稳定性受到损害。在较低温度下干燥的样品更均匀,并且在三个月内保持稳定。发现蔗糖或海藻糖与甘露醇的最佳比例为3:2,总浓度为10%,以实现最佳稳定性(粒度<1.0μm,多分散指数<0.250)。冻干保护剂的无定形态可能与纳米晶体提供了高度的相互作用,而结晶甘露醇提供了良好的块状结构。在冷冻干燥过程中,蔗糖在保持粒度方面优于海藻糖,而海藻糖在储存期间将粒度保持在限度内更有效。总之,结果表明,蔗糖/海藻糖和甘露醇的适当组合以及冻干工艺参数的适当选择可以产生具有令人满意稳定性的纳米晶体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验